2CHAN JK. The new World Health Organization classification of the lymphomas:the past, the present and the future[J]. Hematol Oncol, 2001, 19 (4): 129-150.
3Li YX, Fang H, Liu QF, et al. Clinical features and treatment out- come of Nasal type NK/T-cell lymphoma of Waldeyer ring[J]. Blood, 2008, 112(8): 619-625.
4Li CC, Tien HF, Tang JL, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-ceU lymphoma[J]. Cancer, 2004, 100(2): 366-375.
5Isobe K, Uno T, Tamaru J, et al. Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic Parame- ters [Jl. Cancer, 2006, 106(3):609-615.
6Wu X, Li P, Zhao J, et al. A clinical study of 115 patients with extra- nodal natural killer/T-cell lymphoma, nasal type[J]. Clin Oncol, 2008, 20(8): 619-625.
7Koom WS, Chunj EJ, Yang WI, et al. Angioeentric T-cell and NK/ T-cell Lymphomas: radiotherapetic viewpoints[J]. Int J Radiat On- col Biol Phys, 2004, 59(4): 1127-1137.
8Chan JK. The new World Health Organization classification of the lymphomas: the past, the present and the future. Hematol Oncol,2001, 19: 129-150.
9Li YX, Fang H, Liu QF, et al. Clinical features and treatment outcome of nasal-type NK/T-eell lymphoma of Waldeyer ring. Blood, 2008, 20: 619-625.
10lsobe K, Uno T, Tamaru J, et al. Extranodal natural killer/T-cell lymphoma, nasal type:the significance of radiotherapeutic Parameters. Cancer, 2006, 106: 609-615.
